FDA Adverse Event Other Summary report: N

INTELLIFILL I.V.

MDR report key: 2222358 · Received August 18, 2011

Report

Report Number
3004771245-2011-00002
Event Type
Other
Date Received
August 18, 2011
Date of Event
January 5, 2011
Report Date
August 18, 2011
Manufacturer
BAZA SYSTEMS DEVELOPMENT CENTER
Product Code
NEP
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

THIS MDR IS BEING FILED RETROSPECTIVELY DUE TO A ROUTINE MONITORING OF THE MAUDE DATABASE ON (B)(4) 2011. (PAGE 3 OF 4 AND PAGE 4 OF 4) WITH NARRATIVE. IN CONCLUSION, THE POSITIVE GROWTH SYRINGES REPORTED BY OUR CUSTOMER, (B)(6), WAS LIKELY CAUSED BY A NUMBER OF FACTORS. THE MONITORING PROGRAM AND THE INTELLIFILL I.V. DEVICE OPERATED AS INTENDED.

Description of Event or Problem · 1

A ROUTINE MONITORING OF THE MAUDE DATABASE ON (B)(6) 2011 BAXA LEARNED THAT A MEDWATCH THAT WAS REPORTED ON (B)(6) 2011. AS A RESULT BAXA SYSTEMS DEVELOPMENT CENTER IS FILING THIS MDR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INTELLIFILL I.V. PHARMACY COMPOUND DEVICE NEP BAZA SYSTEMS DEVELOPMENT CENTER INTELLIFILL I.V. NA

Patients

Seq Age Sex Outcome Treatment
1